Clinical characteristics of included patients
| Control | MI | Statistics | |||
| Phase I | Phase II | Phase III | |||
| Total patients | 8 | 12 | 7 | 6 | ns |
| Age (mean±SD) | 60±6 | 66±2 | 72±5 | 64±6 | ns |
| Sex (male/female) | 5/3 | 5/7 | 5/2 | 4/2 | ns |
| DM (type 1/type 2) | 0/0 | 0/1 | 0/0 | 0/0 | ns |
| Prior incidence of MI | 0 | 3 | 2 | 4 | ns |
| Neurological complications | ns | ||||
| Alzheimer’s disease | 1 | ||||
| Cerebral atrophy | 1 | ||||
| Cerebrovascular accident | 1 | ||||
| Metastasis | 1 | ||||
| Parkinson’s disease | 1 | ||||
| Schizophrenia | 1 | ||||
| Cause of death | na | ||||
| Aorta dissection | 3 | ||||
| Cancer | 1 | ||||
| Haemorrhagic shock | 1 | 1 | 1 | ||
| MI | 10 | 6 | 6 | ||
| No cause | 1 | ||||
| Pneumonia | 1 | ||||
| Sepsis | 1 | 1 | |||
DM, diabetes mellitus; MI, myocardial infarction; na, not applicable; ns, not significant.